Tumor site Treatment MSTS
2 weeks 4 weeks
Upper Limb 1humerus Silicate granules 58% 74%
  1 humerus Silicate granules+BMMCs 81% 90%
1 humerus Silicate granules+BMMCs 78% 88%
Lower Limb 1   knees Silicate granules 59% 72%
11 Femur Silicate granules 62% 75%
1   Femur Silicate granules+BMMCs 72% 76%
3   Tibia Silicate granules 51% 65%
1   Tibia Silicate granules+BMMCs 85% 92%
Table 3: Musculoskeletal tumour society functional outcome score (msts) into upper and lower limb.